Journal profile · RESPIRATORY SYSTEM-RESPIRATORY SYSTEM
Lancet Respiratory Medicine
ISSN 2213-2600 · eISSN 2213-2619 · Elsevier Ltd · ENGLAND
Lancet Respiratory Medicine: CAS Zone 1 · Medicine (2025 upgraded edition, Top journal); impact factor 33.51; hybrid open access; APC about USD 7,280; median 59 days to acceptance (71 articles, last 24 months); 265 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Lancet Respiratory Medicine is published by Elsevier Ltd and is in Zone 1 of Medicine in the CAS Journal Ranking (2025 upgraded edition, Top journal). By OpenAlex counts of its recent articles, its largest topics are Chronic Obstructive Pulmonary Disease (COPD) Research, Asthma and respiratory diseases and Respiratory Support and Mechanisms, together about 29.3% of its articles. Its main subfields are Pulmonary and Respiratory Medicine. (generated from OpenAlex topic counts and CAS ranking data)
The Lancet Respiratory Medicine is an authoritative forum for key opinion leaders across medicine, government, and health systems to influence clinical practice, explore global policy, and inform constructive, positive change worldwide. The journal is the global leader for essential original research in critical care and respiratory medicine, and delivers expert review, candid commentary, and breaking news, providing a clear, independent perspective about the clinical advances and practice-changing research shaping these fields globally.
From the journal's Aims & Scope
Research area (LetPub): RESPIRATORY SYSTEM-RESPIRATORY SYSTEM
Main research topics OpenAlex counts of recent articles; shares are approximate
- Chronic Obstructive Pulmonary Disease (COPD) ResearchMedicine11.1%
- Asthma and respiratory diseasesMedicine9.3%
- Respiratory Support and MechanismsMedicine8.9%
- Interstitial Lung Diseases and Idiopathic Pulmonary FibrosisMedicine5.3%
- Neonatal Respiratory Health ResearchMedicine4.9%
- COVID-19 Clinical Research StudiesMedicine4.7%
- Cystic Fibrosis Research AdvancesMedicine4.4%
- Tuberculosis Research and EpidemiologyMedicine4.3%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Critical Care Medicine | Zone 1 |
| Minor | Respiratory System | Zone 1 |
Top journal: yesReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Critical Care Medicine | Zone 1 |
| Minor | Respiratory System | Zone 1 |
Top journal: yesReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Critical Care Medicine | Zone 1 |
| Minor | Respiratory System | Zone 1 |
Top journal: yesReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 33.51LetPub ·
- Impact factor (publisher)
- 34.7Publisher website ·
- CiteScore 2026-06
- 48.1LetPub ·
- CiteScore (publisher)
- 48.1Publisher website ·
- SJR 2026-06
- 7.65LetPub ·
- SNIP 2026-06
- 8.32LetPub ·
- h-index
- 79LetPub ·
- h-index
- 258OpenAlex ·
- i10-index
- 1,631OpenAlex ·
- 2-year mean citedness
- 11.4OpenAlex ·
- Self-citation rate
- 1.4%LetPub ·
- Share of gold OA articles
- 19.32%LetPub ·
Volume
- Articles per year
- 75LetPub ·
Articles by year OpenAlex count · 4,127 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 175 | 36 | 204 |
| 2025 | 265 | 111 | 3,123 |
| 2024 | 241 | 86 | 4,433 |
| 2023 | 272 | 160 | 8,434 |
| 2022 | 307 | 216 | 14,371 |
| 2021 | 387 | 302 | 26,569 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
59 daysMedian, submission to acceptance · P25–P75 11 days – 120 days
- Acceptance to online
- median 65 days (71 articles)
- Submission to online
- median 124 days
- Sample
- 71 articles with submission and acceptance dates (521 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Submission to first decision
- 4 daysPublisher website ·
- First decision after review
- 37 daysPublisher website ·
- Submission to acceptance
- 20 daysPublisher website ·
- Acceptance to publication
- 64 daysPublisher website ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 7,280 / EUR 6,810 / GBP 5,830 / JPY 902,940 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Elsevier Ltd
- Country or region
- ENGLAND
- Language
- English
- ISSN
- 2213-2600
- Electronic ISSN
- 2213-2619
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Lancet Respiratory Medicine
What CAS zone is Lancet Respiratory Medicine in?
In the 2025 upgraded edition of the CAS Journal Ranking, Lancet Respiratory Medicine is in Zone 1 of Medicine, and in Zone 1 of the minor category Critical Care Medicine / Respiratory System; it is a Top journal. In the 2026 Xinrui edition it is in Zone 1 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Lancet Respiratory Medicine?
The latest impact factor listed by LetPub is 33.51; CiteScore 48.1, h-index 258.
How long does peer review take at Lancet Respiratory Medicine?
Based on the dates recorded on 71 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 59 days (interquartile range 11–120 days). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Lancet Respiratory Medicine?
According to LetPub and DOAJ records, Lancet Respiratory Medicine is indexed in SCIE and Scopus.
Is Lancet Respiratory Medicine open access, and what is the APC?
Lancet Respiratory Medicine is a hybrid journal. For open-access publication: APC about USD 7,280.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .